Japan's Kirin Agrees to Buy Jamieson Wellness for US$1.36 Billion
By Kosaku Narioka
Kirin Holdings has agreed to acquire century-old Canadian supplement company Jamieson Wellness for US$1.36 billion in a bid to strengthen its health science business in North America.
The Japanese beverage maker said Friday that it planned to buy all shares of Jamieson Wellness for 1.90 billion Canadian dollars.
Kirin said the health science business is a key driver of growth. In recent years, it acquired Australian nutritional supplement maker Blackmores and Japanese cosmetics and dietary-supplement maker Fancl as part of efforts to expand the health business.
Kirin said it is aiming to strengthen its operations in North America, the world's largest market for supplements. The Japanese company said Jamieson Wellness, founded in 1922, has built a strong brand and sales network in the region.
The acquisition is subject to certain conditions and approvals, including one from the Canadian company's shareholders. The transaction is expected to be completed in October or later. Kirin plans to pay C$45.75 per share.
Jamieson Wellness said its board unanimously approved the acquisition plan.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
August 06, 2026 22:14 ET (02:14 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States